Michael Klompas1,2, Peter B Imrey3,4, Pei-Chun Yu3,5, Chanu Rhee1,2, Abhishek Deshpande5, Sarah Haessler6, Marya D Zilberberg7, Michael B Rothberg5. 1. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts. 2. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. 3. Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio. 4. Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio. 5. Center for Value-Based Care Research, Cleveland Clinic, Cleveland, Ohio. 6. Department of Medicine, Division of Infectious Diseases, University of Massachusetts Medical School-Baystate, Springfield, Massachusetts. 7. EviMed Research Group, LLC, Goshen, Massachusetts.
Abstract
OBJECTIVE: Viruses are more common than bacteria in patients hospitalized with community-acquired pneumonia. Little is known, however, about the frequency of respiratory viral testing and its associations with antimicrobial utilization. DESIGN: Retrospective cohort study. SETTING: The study included 179 US hospitals. PATIENTS: Adults admitted with pneumonia between July 2010 and June 2015. METHODS: We assessed the frequency of respiratory virus testing and compared antimicrobial utilization, mortality, length of stay, and costs between tested versus untested patients, and between virus-positive versus virus-negative patients. RESULTS: Among 166,273 patients with pneumonia on admission, 40,787 patients (24.5%) were tested for respiratory viruses, 94.8% were tested for influenza, and 20.7% were tested for other viruses. Viral assays were positive in 5,133 of 40,787 tested patients (12.6%), typically for influenza and rhinovirus. Tested patients were younger and had fewer comorbidities than untested patients, but patients with positive viral assays were older and had more comorbidities than those with negative assays. Blood cultures were positive for bacterial pathogens in 2.7% of patients with positive viral assays versus 5.3% of patients with negative viral tests (P < .001). Antibacterial courses were shorter for virus-positive versus -negative patients overall (mean 5.5 vs 6.4 days; P < .001) but varied by bacterial testing: 8.1 versus 8.0 days (P = .60) if bacterial tests were positive; 5.3 versus 6.1 days (P < .001) if bacterial tests were negative; and 3.3 versus 5.2 days (P < .001) if bacterial tests were not obtained (interaction P < .001). CONCLUSIONS: A minority of patients hospitalized with pneumonia were tested for respiratory viruses; only a fraction of potential viral pathogens were assayed; and patients with positive viral tests often received long antibacterial courses.
OBJECTIVE: Viruses are more common than bacteria in patients hospitalized with community-acquired pneumonia. Little is known, however, about the frequency of respiratory viral testing and its associations with antimicrobial utilization. DESIGN: Retrospective cohort study. SETTING: The study included 179 US hospitals. PATIENTS: Adults admitted with pneumonia between July 2010 and June 2015. METHODS: We assessed the frequency of respiratory virus testing and compared antimicrobial utilization, mortality, length of stay, and costs between tested versus untested patients, and between virus-positive versus virus-negative patients. RESULTS: Among 166,273 patients with pneumonia on admission, 40,787 patients (24.5%) were tested for respiratory viruses, 94.8% were tested for influenza, and 20.7% were tested for other viruses. Viral assays were positive in 5,133 of 40,787 tested patients (12.6%), typically for influenza and rhinovirus. Tested patients were younger and had fewer comorbidities than untested patients, but patients with positive viral assays were older and had more comorbidities than those with negative assays. Blood cultures were positive for bacterial pathogens in 2.7% of patients with positive viral assays versus 5.3% of patients with negative viral tests (P < .001). Antibacterial courses were shorter for virus-positive versus -negative patients overall (mean 5.5 vs 6.4 days; P < .001) but varied by bacterial testing: 8.1 versus 8.0 days (P = .60) if bacterial tests were positive; 5.3 versus 6.1 days (P < .001) if bacterial tests were negative; and 3.3 versus 5.2 days (P < .001) if bacterial tests were not obtained (interaction P < .001). CONCLUSIONS: A minority of patients hospitalized with pneumonia were tested for respiratory viruses; only a fraction of potential viral pathogens were assayed; and patients with positive viral tests often received long antibacterial courses.
Authors: Seema Jain; Wesley H Self; Richard G Wunderink; Sherene Fakhran; Robert Balk; Anna M Bramley; Carrie Reed; Carlos G Grijalva; Evan J Anderson; D Mark Courtney; James D Chappell; Chao Qi; Eric M Hart; Frank Carroll; Christopher Trabue; Helen K Donnelly; Derek J Williams; Yuwei Zhu; Sandra R Arnold; Krow Ampofo; Grant W Waterer; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Jonathan A McCullers; Andrew T Pavia; Kathryn M Edwards; Lyn Finelli Journal: N Engl J Med Date: 2015-07-14 Impact factor: 91.245
Authors: Valerie M Vaughn; Scott A Flanders; Ashley Snyder; Anna Conlon; Mary A M Rogers; Anurag N Malani; Elizabeth McLaughlin; Sarah Bloemers; Arjun Srinivasan; Jerod Nagel; Scott Kaatz; Danielle Osterholzer; Rama Thyagarajan; Lama Hsaiky; Vineet Chopra; Tejal N Gandhi Journal: Ann Intern Med Date: 2019-07-09 Impact factor: 25.391
Authors: Christopher F Lowe; Michael Payne; David Puddicombe; Allison Mah; Davie Wong; Allison Kirkwood; Mark W Hull; Victor Leung Journal: Am J Infect Control Date: 2017-05-16 Impact factor: 2.918
Authors: David T Huang; Donald M Yealy; Michael R Filbin; Aaron M Brown; Chung-Chou H Chang; Yohei Doi; Michael W Donnino; Jonathan Fine; Michael J Fine; Michelle A Fischer; John M Holst; Peter C Hou; John A Kellum; Feras Khan; Michael C Kurz; Shahram Lotfipour; Frank LoVecchio; Octavia M Peck-Palmer; Francis Pike; Heather Prunty; Robert L Sherwin; Lauren Southerland; Thomas Terndrup; Lisa A Weissfeld; Jonathan Yabes; Derek C Angus Journal: N Engl J Med Date: 2018-05-20 Impact factor: 91.245
Authors: Frank van Someren Gréve; Nicole P Juffermans; Lieuwe D J Bos; Jan M Binnekade; Annemarije Braber; Olaf L Cremer; Evert de Jonge; Richard Molenkamp; David S Y Ong; Sjoerd P H Rebers; Angelique M E Spoelstra-de Man; Koenraad F van der Sluijs; Peter E Spronk; Kirsten D Verheul; Monique C de Waard; Rob B P de Wilde; Tineke Winters; Menno D de Jong; Marcus J Schultz Journal: Crit Care Med Date: 2018-01 Impact factor: 7.598
Authors: Alejandro H Rodríguez; Francesc X Avilés-Jurado; Emili Díaz; Philipp Schuetz; Sandra I Trefler; Jordi Solé-Violán; Lourdes Cordero; Loreto Vidaur; Ángel Estella; Juan C Pozo Laderas; Lorenzo Socias; Juan C Vergara; Rafael Zaragoza; Juan Bonastre; José E Guerrero; Borja Suberviola; Catia Cilloniz; Marcos I Restrepo; Ignacio Martín-Loeches Journal: J Infect Date: 2015-12-15 Impact factor: 6.072
Authors: Michael Silverman; Marcus Povitz; Jessica M Sontrop; Lihua Li; Lucie Richard; Sonny Cejic; Salimah Z Shariff Journal: Ann Intern Med Date: 2017-05-09 Impact factor: 25.391
Authors: Angela R Branche; Edward E Walsh; Roberto Vargas; Barbara Hulbert; Maria A Formica; Andrea Baran; Derick R Peterson; Ann R Falsey Journal: J Infect Dis Date: 2015-04-24 Impact factor: 5.226
Authors: Patricia S Bartley; Abhishek Deshpande; Pei-Chun Yu; Michael Klompas; Sarah D Haessler; Peter B Imrey; Marya D Zilberberg; Michael B Rothberg Journal: Infect Control Hosp Epidemiol Date: 2021-04-23 Impact factor: 6.520